Peter Goadsby, MD discusses the efficacy, safety, & tolerability of the CGRP inhibitor erenumab in a phase III trial of participants with episodic migraine.
Menstrual Migraine: Therapeutic Approaches
This large population subset can potentially benefit from therapies that are more directly targeted to hormonally-influenced migraine headaches.
Interesting Neuro: Stroke Warning & Cluster Headache
May news includes ground-breaking FDA approvals, predictions of Alzheimer disease, and a possible biomarker for mild traumatic brain injury.
CGRP-Targeting Erenumab for Chronic Migraine
For several decades, studies have suggested a role for CGRP in migraine, and that targeting the CGRP pathway might help to prevent migraine.
Migraine Risk by Body Composition
Researchers examined two possible risk factors for migraine that potentially can be modified – having obesity and being underweight.
Neuro News Roundup: Migraine & MS Risks
Research includes impact of body weight on migraine risk, effect of sleep on MS relapse, and side effects of statins in stroke survivors.
5 New Neurology Technologies
From the first hand-held vagus nerve stimulator for episodic cluster headache to a TMS therapy system for depression, we highlight 5 new technologies.
Migraine Prevention: Promising New Drug
Interesting Neuro: New Drugs & TBI Recovery
April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
By clicking Accept, you agree to become a member of the UBM Medica Community.